The Ministry of Commerce and Trade has clarified that no further tariffs have been imposed on Indian exports to america within the pharmaceutical and electronics sectors. As per a written reply within the Lok Sabha, this announcement would convey reduction to exporters in these delicate sectors going through considerations about doable responsibility hikes.
Within the meantime, the Ministry stated that different items have been subjected to a reciprocal tariff of 25% from August 7 and that this is applicable to round 55% in worth of India merchandise exports to the US. Moreover, on August 27, the advert valorem responsibility of 25% on sure items will come into being.
The federal government undertakes consultations with stakeholders, together with exporters, MSMEs, and the trade, for the evaluation of those measures. It was emphasised that high precedence will proceed to be given to defending the curiosity of farmers, staff, entrepreneurs, and all sections of the trade.
On the commerce diplomacy entrance, India and the US are persevering with negotiations on a Bilateral Commerce Settlement (BTA) aimed toward enhancing market entry, decreasing tariff and non-tariff limitations, and bettering provide chain integration. Talks started in March 2025, with 5 rounds accomplished up to now the most recent held in Washington from July 14 to 18. The US delegation is about to reach in India by the tip of August for the sixth spherical of Bilateral Commerce Settlement negotiation.
The Division of Commerce is carefully monitoring the scenario to judge the potential repercussions of the tariff adjustments and is engaged on methods to mitigate any antagonistic results. Measures equivalent to export promotion and market diversification are being explored to help affected industries.
